Individuals with HA have normal levels of circulating VWF, thus prolonging VWF half-life to also increase FVIII half-life could raise the level of circulating VWF in these individuals, and therefore increase the risk of arterial diseases such as heart attack or stroke. This evidence concerns the gene VWF and myocardial infarction.